James Basta's most recent trade in Intellia Therapeutics Inc was a trade of 57,143 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intellia Therapeutics Inc | James Basta | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 57,143 | 57,143 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | James Basta | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 40,000 | 114,497 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | James Basta | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 8.99 per share. | 01 Mar 2025 | 2,572 | 111,925 (0%) | 0% | 9.0 | 23,122 | Common Stock |
| Intellia Therapeutics Inc | James Basta | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 12.18 per share. | 03 Jan 2025 | 7,074 | 74,497 (0%) | 0% | 12.2 | 86,161 | Common Stock |
| Intellia Therapeutics Inc | James Basta | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 46,752 | 46,752 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | James Basta | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 32,394 | 83,868 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | James Basta | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 32.99 per share. | 01 Mar 2024 | 2,297 | 81,571 (0%) | 0% | 33.0 | 75,778 | Common Stock |
| Intellia Therapeutics Inc | Basta James | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 29.46 per share. | 03 Jan 2024 | 3,805 | 51,474 (0%) | 0% | 29.5 | 112,095 | Common Stock |
| Intellia Therapeutics Inc | James Basta | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 34,674 | 34,674 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | James Basta | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 24,539 | 44,098 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | James Basta | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 12,269 | 56,367 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | James Basta | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 43.88 per share. | 01 Mar 2023 | 1,088 | 55,279 (0%) | 0% | 43.9 | 47,741 | Common Stock |
| Intellia Therapeutics Inc | James Basta | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 37.21 per share. | 04 Jan 2023 | 1,138 | 19,559 (0%) | 0% | 37.2 | 42,345 | Common Stock |
| Intellia Therapeutics Inc | James Basta | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 11,049 | 11,049 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | James Basta | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 9,648 | 9,648 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | James Basta | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 9,648 | 20,697 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | James Basta | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 125,000 | 125,000 | - | - | Option to purchase common stock |